NLRP3 and atherosclerosis: Such strategies for harnessing gene-immune signatures may be the future of personalized medicine, whereby a formidable impact of the NETs–NLRP3 inflammasome nexus on atherosclerosis and its affiliated worst outcomes can be curtailed.